Lucas M A Goossens

Summary

Affiliation: Erasmus University
Country: The Netherlands

Publications

  1. ncbi request reprint Should I stay or should I go home? A latent class analysis of a discrete choice experiment on hospital-at-home
    Lucas M A Goossens
    Institute for Medical Technology Assessment Institute for Healthcare Policy and Management, Erasmus University, Rotterdam, The Netherlands Electronic address
    Value Health 17:588-96. 2014
  2. ncbi request reprint Cost-effectiveness of early assisted discharge for COPD exacerbations in The Netherlands
    Lucas M A Goossens
    Institute for Medical Technology Assessment, Erasmus University, Rotterdam, The Netherlands
    Value Health 16:517-28. 2013
  3. pmc Adjusting for COPD severity in database research: developing and validating an algorithm
    Lucas M A Goossens
    Institute for Medical Technology Assessment, Erasmus University, Rotterdam, The Netherlands
    Int J Chron Obstruct Pulmon Dis 6:669-78. 2011
  4. pmc Effectiveness and cost-effectiveness of early assisted discharge for chronic obstructive pulmonary disease exacerbations: the design of a randomised controlled trial
    Cecile M A Utens
    Department of Respiratory Medicine, Catharina Hospital Eindhoven, Eindhoven, The Netherlands
    BMC Public Health 10:618. 2010
  5. doi request reprint An economic evaluation of budesonide/formoterol for maintenance and reliever treatment in asthma in general practice
    Lucas M A Goossens
    Institute for Medical Technology Assessment, Erasmus University Medical Center, DR Rotterdam, The Netherlands
    Adv Ther 26:872-85. 2009
  6. doi request reprint Is the EQ-5D responsive to recovery from a moderate COPD exacerbation?
    Lucas M A Goossens
    Institute for Medical Technology Assessment, Erasmus University, Rotterdam, The Netherlands
    Respir Med 105:1195-202. 2011
  7. doi request reprint Cost effectiveness of pharmacological maintenance treatment for chronic obstructive pulmonary disease: a review of the evidence and methodological issues
    Maureen P M H Rutten-van Mölken
    Institute for Medical Technology Assessment Institute for Healthcare Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands
    Pharmacoeconomics 30:271-302. 2012
  8. doi request reprint The cost-utility of rotavirus vaccination with Rotarix (RIX4414) in the Netherlands
    Lucas M A Goossens
    Institute for Medical Technology Assessment, Erasmus University Medical Center, Rotterdam, The Netherlands
    Vaccine 26:1118-27. 2008

Detail Information

Publications8

  1. ncbi request reprint Should I stay or should I go home? A latent class analysis of a discrete choice experiment on hospital-at-home
    Lucas M A Goossens
    Institute for Medical Technology Assessment Institute for Healthcare Policy and Management, Erasmus University, Rotterdam, The Netherlands Electronic address
    Value Health 17:588-96. 2014
    ..This technique is rarely used in health economics...
  2. ncbi request reprint Cost-effectiveness of early assisted discharge for COPD exacerbations in The Netherlands
    Lucas M A Goossens
    Institute for Medical Technology Assessment, Erasmus University, Rotterdam, The Netherlands
    Value Health 16:517-28. 2013
    ..An alternative is to treat suitable patients at home instead of in the hospital. This article reports on the cost-effectiveness and cost-utility of early assisted discharge in The Netherlands...
  3. pmc Adjusting for COPD severity in database research: developing and validating an algorithm
    Lucas M A Goossens
    Institute for Medical Technology Assessment, Erasmus University, Rotterdam, The Netherlands
    Int J Chron Obstruct Pulmon Dis 6:669-78. 2011
    ..Previous database research has approximated COPD severity using demographics and healthcare utilization. This study aims to derive an algorithm for COPD severity using baseline data from a large respiratory trial (UPLIFT)...
  4. pmc Effectiveness and cost-effectiveness of early assisted discharge for chronic obstructive pulmonary disease exacerbations: the design of a randomised controlled trial
    Cecile M A Utens
    Department of Respiratory Medicine, Catharina Hospital Eindhoven, Eindhoven, The Netherlands
    BMC Public Health 10:618. 2010
    ..Whether this type of service is cost-effective depends on the setting in which it is delivered and the way in which it is organised...
  5. doi request reprint An economic evaluation of budesonide/formoterol for maintenance and reliever treatment in asthma in general practice
    Lucas M A Goossens
    Institute for Medical Technology Assessment, Erasmus University Medical Center, DR Rotterdam, The Netherlands
    Adv Ther 26:872-85. 2009
    ..This study assesses the cost-effectiveness of SMART compared with usual care in patients with mild-to-moderate persistent asthma treated by general practitioners in the Netherlands from a societal perspective...
  6. doi request reprint Is the EQ-5D responsive to recovery from a moderate COPD exacerbation?
    Lucas M A Goossens
    Institute for Medical Technology Assessment, Erasmus University, Rotterdam, The Netherlands
    Respir Med 105:1195-202. 2011
    ..To correctly estimate the cost-effectiveness of treatments that reduce COPD exacerbations, the utility gains from preventing exacerbations need to be measured. This requires utility measurement during exacerbations...
  7. doi request reprint Cost effectiveness of pharmacological maintenance treatment for chronic obstructive pulmonary disease: a review of the evidence and methodological issues
    Maureen P M H Rutten-van Mölken
    Institute for Medical Technology Assessment Institute for Healthcare Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands
    Pharmacoeconomics 30:271-302. 2012
    ..Guidelines for the pharmacological treatment of the disease recommend an individualized step-up approach in which treatment is intensified when results are unsatisfactory...
  8. doi request reprint The cost-utility of rotavirus vaccination with Rotarix (RIX4414) in the Netherlands
    Lucas M A Goossens
    Institute for Medical Technology Assessment, Erasmus University Medical Center, Rotterdam, The Netherlands
    Vaccine 26:1118-27. 2008
    ..Based on the current study, it is clear that mass vaccination with Rotarix against rotavirus gastroenteritis can be attractive, from an economic and a health care perspective...